Company
United StatesPublic company, NASDAQ: HRTXHeron Therapeutics, Inc. (NASDAQ: HRTX), Redwood City, CA – FDA Inspections
Inspection records and compliance data for Heron Therapeutics, Inc. in Redwood City, California. 3 FDA inspections on record (1 OAI), last inspected January 06, 2016. Publicly traded as NASDAQ: HRTX.
Company Profile
This profile covers Heron Therapeutics, Inc. based in Redwood City, California, United States.
FDA Inspection History
- FDA inspections
- 3
- OAI
- 1
- VAI
- 0
- NAI
- 2
- Form 483s
- 0
- Warning letters
- 0
First inspected January 21, 2010. Last inspected January 6, 2016.
FDA inspections (3)
| Date | Result | FDA center(s) | Insp. # |
|---|---|---|---|
| January 6, 2016 | NAI | Medical Devices & Rad Health · Compliance: Devices | 977004 |
| November 20, 2015 | NAI | Human Drugs · Drug Quality Assurance | 950486 |
| January 21, 2010 | OAI | Human Drugs · Drug Quality Assurance | 640101 |
FDA documents
EIRs (1)
Related Companies (10)
Companies with similar regulatory profiles, compliance history, and operations.
Company Information
Name
Heron Therapeutics, Inc.
Stock ticker
HRTX
Exchange
NASDAQ
Share price
$0.33
Market cap
$62.0M
Price as of
November 13, 2026
FEI Number
3006138169
Address
123 Saginaw Dr, Redwood City, California 94063, United States
Country
United States
ID: b58e58c3-d3d5-429f-9ca7-0abd827c854b